johnson & johnson - Search News

FDA approves Johnson & Johnson’s nasal spray for depression

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

U.S. News & World Report · 1d

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral antidepressants,

Popular Science · 1d

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

Bears hire Ben Johnson

USA Today · 1d

Ben Johnson introduced as Bears head coach: 'I wanted to stay in this division'

Ben Johnson expressed gratitude for his time with the Detroit Lions head coach, calling Dan Campbell a "friend" and "mentor" as he takes over Bears

Chicago Sun-Times · 1d

Bears landed Ben Johnson, who didn't want to be anywhere else

The Bears had targeted Johnson as their top candidate since firing head coach Matt Eberflus the day after Thanksgiving. They were convinced that his play-calling acumen and leadership skills were a perfect pairing with quarterback Caleb Williams and the rest of the Bears’ roster.

Fox News · 5h

Ben Johnson on joining the Bears and sharing accountability | Breakfast Ball

Ben Johnson joins Craig Carton, Danny Parkins, and Mark Schlereth to discuss joining the Chicago Bears as their next head coach. He talks about building a culture with Caleb Williams, and what his first season might look like.

Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

11h

Johnson & Johnson: Hold Rating Amid Mixed Performance and Future Uncertainties

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...

10h

‘How dare you’: Kinzinger calls out Johnson’s defense of Trump’s pardons

Former GOP congressman Adam Kinzinger criticized House Speaker Mike Johnson for defending President Trump’s pardons and ...

Update: Man charged with attempted murder in Johnson County arrested

JOHNSON COUNTY, Tenn. (WCYB) — Update: The suspect arrested in Elizabethton following a shooting in Johnson County has been ...

12h

Balanced Expectations Amid Challenges and Opportunities for Johnson & Johnson: Hold Rating Issued

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee ...

53m

Lions GM Shares Why Team Has No Concern Over Jared Goff Without Ben Johnson

The Detroit Lions lost both their offensive and defensive coordinators as Ben Johnson and Aaron Glenn both accepted head coaching positions this past week. The Lions' leadership will look different ...

Johnson County Sheriff's Office investigating shooting

The Johnson County Sheriff's Office said that they are investigating a shooting on Wednesday.Police said that just before ...

10h

Johnson & Johnson price target lowered to $155 from $170 at Stifel

Stifel analyst Rick Wise lowered the firm’s price target on Johnson & Johnson to $155 from $170 and keeps a Hold rating on the shares.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA approves Johnson & Johnson’s nasal spray for depression

Bears hire Ben Johnson

Related topics